Reward for persistence in substance P research.
Wahlestedt
C
C
Center for Genomics Research, Karolinska Institute, Stockholm, Sweden. Claes.Wahlestedt@cgr.ki.se
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use*; D000077608:Aprepitant; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D017322:Clinical Trials, Phase II as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D009025:Morpholines / Q000494:pharmacology / Q000627:therapeutic use*; D064729:Neurokinin-1 Receptor Antagonists; D013373:Substance P / Q000037:antagonists & inhibitors* / Q000378:metabolism
D014151:Anti-Anxiety Agents; D018687:Antidepressive Agents, Second-Generation; D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D000077608:Aprepitant; D013373:Substance P